Declared bankruptcy in Sep 2023
Company logo

SRGA - Surgalign Holdings, Inc.

NASDAQ -> Healthcare -> Medical Devices
Deerfield, United States
Type: Equity

SRGA price evolution
SRGA
(in millions $) 31 Mar 2023 31 Jan 2023 30 Sep 2022 30 Jun 2022
Current assets
Cash $22.43 $16.3 $13.85 $29.34
Short term investments
Net receivables $12.57 $21.77 $18.94 $20.5
Inventory $19.68 $17.71 $38.32 $37.07
Total current assets $53.43 $56.71 $66.65 $86.8
Long term investments
Property, plant & equipment $2.42 $3.02 $1.78 $1.32
Goodwill & intangible assets
Total noncurrent assets $14.28 $13.53 $21.39 $18.89
Total investments
Total assets $67.71 $70.24 $88.04 $105.7
Current liabilities
Accounts payable $7.49 $7.71 $13.06 $10.56
Deferred revenue
Short long term debt
Total current liabilities $19.98 $21.15 $34.69 $37.25
Long term debt $10.24 $10.19 $10.14 $10.09
Total noncurrent liabilities $56.66 $64.82 $30.97 $37.61
Total debt $10.24 $10.19 $10.14 $10.09
Total liabilities $76.64 $85.97 $65.66 $74.86
Shareholders' equity
Retained earnings -$620.07 -$624.22 -$585.11 -$575.27
Other shareholder equity -$3.35 -$2.84 -$2.06 -$2.24
Total shareholder equity -$18.93 -$25.73 $12.38 $20.84
(in millions $) 31 Jan 2023 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $16.3 $51.29 $43.96 $5.61
Short term investments
Net receivables $21.77 $19.2 $27.09 $59.29
Inventory $17.71 $36.42 $30.7 $130.79
Total current assets $56.71 $105.67 $104.18 $195.81
Long term investments
Property, plant & equipment $3.02 $0.94 $0.52 $69.89
Goodwill & intangible assets $65.88
Total noncurrent assets $13.53 $18.13 $18.52 $148.69
Total investments
Total assets $70.24 $123.8 $122.7 $344.51
Current liabilities
Accounts payable $7.71 $10.2 $13.42 $30.13
Deferred revenue $2.75
Short long term debt $174.18
Total current liabilities $21.15 $54.04 $46.82 $240.39
Long term debt $10.19 $9.98
Total noncurrent liabilities $64.82 $51.51 $51.71 $3.15
Total debt $10.19 $9.98 $174.18
Total liabilities $85.97 $105.56 $98.53 $243.53
Shareholders' equity
Retained earnings -$624.22 -$569.61 -$484.96 -$451.18
Other shareholder equity -$2.84 -$1.82 -$2.42 -$7.63
Total shareholder equity -$25.73 $8.24 $24.17 $34.56
(in millions $) 1 May 2023 31 Dec 2022 30 Sep 2022 30 Jun 2022
Revenue
Total revenue $20.57 $20.18 $20.62
Cost of revenue $23.38 $5.49 $6.41
Gross Profit -$2.81 $14.69 $14.21
Operating activities
Research & development $3.33 $3.87 $4.08
Selling, general & administrative $22.43 $23.86 $24.29
Total operating expenses $45.35 $22.69 $27.6
Operating income -$48.16 -$8 -$13.39
Income from continuing operations
EBIT -$40.19 -$9.54 -$5.34
Income tax expense -$1.33 $0.04 $0.09
Interest expense $0.25 $0.25 $0.25
Net income
Net income -$39.11 -$9.83 -$5.69
Income (for common shares) -$39.11 -$9.83 -$5.69
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $81.98 $90.5 $101.75 $308.38
Cost of revenue $41.69 $29.77 $44 $137.26
Gross Profit $40.29 $60.73 $57.75 $171.13
Operating activities
Research & development $15.74 $13.89 $11.95 $16.84
Selling, general & administrative $95.89 $104.67 $124.39 $157.68
Total operating expenses $118.75 $198.01 $255.77 $352.98
Operating income -$78.46 -$137.28 -$198.02 -$181.86
Income from continuing operations
EBIT -$54.64 -$85.54 -$37.24 -$181.83
Income tax expense -$1.04 -$0.89 -$3.49 $17.24
Interest expense $1.01 $0.03 $12.57
Net income
Net income -$54.6 -$84.65 -$33.78 -$211.64
Income (for common shares) -$54.6 -$84.65 -$33.78 -$211.64
(in millions $) 1 May 2023 31 Dec 2022 30 Sep 2022 30 Jun 2022
Net income -$39.11 -$9.83 -$5.69
Operating activities
Depreciation $0.45 $0.55 $0.62
Business acquisitions & disposals
Stock-based compensation $1.12 $1.21 $0.93
Total cash flows from operations -$6.32 -$13.38 -$13.27
Investing activities
Capital expenditures -$1.59 -$2.16 -$1.77
Investments
Total cash flows from investing $15.67 -$1.72 -$2.32 -$1.88
Financing activities
Dividends paid
Sale and purchase of stock $10.89 -$0.01 $0.14
Net borrowings
Total cash flows from financing -$0.02 $10.89 -$0.01 $0.14
Effect of exchange rate -$0.49 -$0.4 $0.21 -$0.32
Change in cash and equivalents $6.13 $2.45 -$15.5 -$15.33
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$54.6 -$84.65 -$33.78 -$211.64
Operating activities
Depreciation $2.18 $2.48 $6.58 $22.68
Business acquisitions & disposals -$10.76 $404.98 -$99.69
Stock-based compensation $4.63 $5.21 $6.53 $4.37
Total cash flows from operations -$52.11 -$51.79 -$88.04 -$9.46
Investing activities
Capital expenditures -$6.78 -$13.42 -$10.12 -$14.43
Investments
Total cash flows from investing -$7.26 -$24.83 $390.94 -$116.13
Financing activities
Dividends paid
Sale and purchase of stock $28.74 $82.56 -$0.49 $0.12
Net borrowings -$196.03 $120.17
Total cash flows from financing $24.66 $82.56 -$263.04 $120.3
Effect of exchange rate -$0.28 $1.39 -$1.51 -$0.06
Change in cash and equivalents -$34.99 $7.33 $38.35 -$5.34
Fundamentals
Market cap $85.62K
Enterprise value -$12.10M
Shares outstanding 7.78M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio -0.01
Book/Share -2.00
Cash/Share 2.88
EPS N/A
ROA N/A
ROE N/A
Debt/Equity -3.34
Net debt/EBITDA N/A
Current ratio 2.67
Quick ratio 1.69